Why People Search for "Buy Iboga Root Bark Online"
Clinical ibogaine treatment costs money, takes travel, and usually means weeks on a waitlist. Raw iboga root bark, by contrast, is a few clicks and a shipping address away from dozens of online vendors. For someone staring down opioid withdrawal at 3 a.m., that difference feels enormous. It is also exactly the gap where most of the documented harm in ibogaine's history has clustered.
This is not a buyer's guide. It is an explanation of what you are actually purchasing when you order "iboga root bark" online, why the number on the label is close to meaningless, and what that means for anyone tempted to dose it at home without medical supervision.
The Product You Receive Is Not a Known Quantity
A laboratory analysis of 16 iboga-derived products collected from treatment providers and online sellers used gas chromatography and mass spectrometry to measure actual ibogaine content (Bouso et al., 2020). Products sold specifically as "iboga root bark" ranged from 0.6% to 11.2% ibogaine content, a nearly 19-fold spread between the weakest and the strongest sample tested. Products labeled Total Alkaloids (TA) ranged from 8.2% to 32.9%. One sample sold as root bark contained no detectable iboga alkaloids at all. Two others contained less than 1%.
The same paper references a prior fatality in which a product sold as iboga root bark was later identified as Rauvolfia powder, an entirely different plant containing no iboga alkaloids, which the buyer had no way of distinguishing from the real thing before ingestion. Separately, forensic cases have found other substances mixed into iboga products sold to patients, including reserpine, a blood-pressure-lowering compound that can compound ibogaine's own cardiovascular effects and is metabolized through the same liver pathway (Bouso et al., 2020).
None of this is a labeling problem a more careful vendor could fix with better packaging. There is no regulated iboga supply chain. Alkaloid content depends on which part of the root was used, how the plant was grown, how it was dried and stored, and how it was processed before sale, none of which shows up on a product page.
What "Weighing Out a Dose" Actually Means Here
This is where the math breaks down in a way that matters. Clinical ibogaine dosing is calculated in milligrams of ibogaine per kilogram of body weight, using a product of known, tested purity. Our dosage guide walks through how flood doses, test doses, and microdoses are calculated in that controlled context.
Weighing out grams of root bark is not the same calculation; it is a guess wearing the clothes of a calculation. If the alkaloid content of your specific batch happens to sit near the low end of that measured range, a dose based on a "normal" assumption will do very little. If it sits near the high end, the same gram weight can deliver several times the intended alkaloid load, with no warning sign before the physiological effects start. This variability sits on top of ibogaine's already well-documented cardiac risk; our breakdown of QT prolongation risk and our review of documented ibogaine-related deaths cover why that risk specifically, not just "something could go wrong" in the abstract, is the mechanism that has killed people.
What This Looks Like in Practice
You do not have to take our word for how this plays out. Our own community has threads that illustrate the exact problem from the inside. In "30g Iboga root bark," and separately in "3g Root Bark Test Dose," people are working out dosing in grams of plant material, the same unit the lab analysis above shows is nearly meaningless without knowing the batch's actual alkaloid percentage. A thread titled "Comparisons between Iboga root bark, TA and Ibogaine" shows members actively trying to reason through exactly the plant-vs-molecule distinction we cover in our companion piece on iboga vs ibogaine: the plant is not a standardized dose, the purified alkaloid is.
Perhaps the most telling thread is "DIY electrocardiogram?" in our Safety & Science category. The fact that someone is researching how to monitor their own heart rhythm at home before a self-administered dose is not a sign of recklessness. It is a sign that people understand the cardiac risk is real and are trying, with whatever tools they have, to compensate for the complete absence of medical supervision. A consumer-grade EKG app or wearable is not equipped to catch the kind of rapid, severe QT prolongation and arrhythmia documented in ibogaine case reports, several of which occurred in supervised treatment settings with real cardiac monitoring in place and still required emergency resuscitation. Attempting to replicate that safety net at home with a smartwatch is not the same thing, and should not be mistaken for it.
If You're Considering This Because Clinical Treatment Feels Out of Reach
We are not going to pretend the barriers to legitimate treatment are imaginary. Cost, travel, and waitlists are real obstacles, and our cost breakdown and guide to what "cheap" treatment actually risks exist because we think people deserve honest numbers instead of being quietly pushed toward unsupervised alternatives by sticker shock.
If you are weighing self-administration against the cost of supervised care, the honest comparison is not "some risk vs. no risk." It is unmeasured, uncontrolled risk against a treatment setting designed specifically around the cardiac danger that kills people when it goes wrong, including cardiologist oversight, continuous ECG monitoring, and emergency protocols if something does go sideways, the exact criteria our Safety Score system was built to verify before a center ever gets listed. Our guide to identifying a legitimate clinic and our list of who should not use ibogaine at all are the next steps we would point you toward before any decision involving a substance with this specific risk profile.